Hims & Hers AI Patient Intake: How a $5B Telehealth Brand Replaced Forms with Conversations

TL;DR#

Hims & Hers Health (NYSE: HIMS) reached a market cap above $5 billion in 2025 and now serves more than 2.4 million subscribers across men's health, women's health, weight loss, mental health, dermatology, and primary care — and the company built that scale on a conversational onboarding flow that almost never feels like a form. The "intake" on hims.com and forhers.com is a quasi-medical-history conversation: one screen, one question, branching logic, and a clinician review at the end. That design choice is why Hims & Hers converted GLP-1 weight loss into a reported $1.2 billion annualized run-rate inside 18 months while legacy telehealth competitors are still building intake on multi-page form wizards. For other healthcare orgs — telehealth startups, multi-specialty clinics, hospital systems — the lesson is not "copy hims.com." It's that ai patient intake healthcare workflows have moved from forms to conversations, and the engineering budget needed to ship that experience has collapsed from "Hims & Hers scale" to "a weekend with an AI interview platform."

What is ai patient intake healthcare?#

AI patient intake healthcare is the use of conversational AI — typically a chat or voice agent — to collect medical history, symptoms, eligibility data, and consent from a patient before a clinician sees them, replacing the static PDF or web form that has dominated digital intake since the late 2000s. The modern version is asynchronous, HIPAA-aware, branches dynamically based on what the patient says, and hands a structured chart note to the prescribing clinician rather than a 14-field form printout.

Hims & Hers' 2026 Scale and Product Surface#

Hims & Hers is no longer a men's hair-loss DTC brand — it is a multi-specialty telehealth platform operating in 50 states. As of the company's most recent investor disclosures the surface includes:

• Men's health — hair loss (finasteride, minoxidil), ED (sildenafil, tadalafil), skincare
• Women's health — birth control, skincare, anti-aging, hair, libido, sexual health
• Weight loss — GLP-1 medications (compounded semaglutide and, where in scope, branded), oral options, behavioral coaching
• Mental health — anxiety, depression, ADHD assessment in pilot markets, sleep
• Primary care — launched 2025, generalist clinician access via the same conversational intake pattern
• Dermatology — acne, rosacea, melasma, custom-compounded topicals

A few load-bearing numbers from public filings and earnings calls that any healthcare product team should know:

The platform's gross margin sits above 75% — unusually high for healthcare delivery — and the single biggest contributor to that margin is automation of the intake-to-prescription step. Every form that doesn't get filled by a human is a clinician-minute the company doesn't pay for.

For context on how this compares to other telehealth platforms scaling intake, see the analysis of how Teladoc handles 80 million visits a year with conversational triage and the Maven Clinic women's-health onboarding playbook.

The Conversational Onboarding Flow (And Why It Converts)#

The Hims & Hers intake works less like a medical questionnaire and more like a texting conversation with a friend who happens to be a nurse. Open hims.com today, click any product, and the funnel follows this shape:

1. Goal selection. One question, big buttons. "What brings you in?" — not "Please complete the following 14-field assessment."
2. Demographic anchoring. Age, state of residence, height/weight if relevant — one at a time.
3. Symptom or condition probe. Branching logic. Hair loss at the temples triggers timeline and family history; weight-loss goal pivots to BMI, comorbidities, and prior attempts.
4. Medical safety screens. Contraindications, medications, allergies — asked conversationally, free text first, normalized in the background.
5. Identity verification. Photo ID, sometimes a selfie. The patient is 60–80% committed by now, which is why ID upload converts higher here than at the front of a form.
6. Async clinician review. A licensed clinician reviews, may message follow-ups, writes a prescription or declines.
7. Fulfillment and lifecycle. Pharmacy ships. Refills and check-ins reuse the same conversational pattern.

The reason it converts: every step is one micro-commitment. Splitting a form into a sequence of small "yes" steps beats showing all the fields at once — the dynamic documented in the research on static intake forms killing conversion rates and in form abandonment as a CFO problem in 2026.

Second design choice: the flow asks the medically relevant questions and only the medically relevant questions for the chosen path. A man signing up for finasteride is never asked about pregnancy intent. A generic HIPAA intake form asks everything because the clinic might one day need it; Hims & Hers asks what matters now.

Third: there is no "Save and continue later" on the early steps. The flow targets a single 6–9 minute session — cross-session completion collapses, a pattern the conversational intake guide documents across verticals.

GLP-1 Expansion and the Intake Design That Enabled It#

The GLP-1 weight-loss product launched in mid-2024 and went from $0 to a reported ~$1.2 billion annualized run-rate in roughly 18 months — one of the fastest-scaling drug categories in DTC history. The intake design is why it scaled rather than collapsed under clinical-review load.

GLP-1s are not finasteride. They are injectables with real contraindications (personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis history, current pregnancy, certain GI conditions) and require dose titration over months. A traditional form-based intake would have either been a 60-question history every patient slogged through (killing conversion) or been short and dangerously incomplete (exposing patients and the company to risk).

The conversational intake threaded the needle by branching aggressively on what the patient said. Most patients answer "no" on contraindications and skim past in seconds. A patient who mentions family history of thyroid cancer gets routed into a deeper sub-flow with priority clinician review. Forms are static; conversations adapt — that's the core capability gap.

When the FDA placed semaglutide and tirzepatide on its shortage list, Hims & Hers pivoted toward compounded semaglutide from 503A and 503B pharmacies. That pivot required intake updates to capture patient-specific eligibility data and disclose compounding status. Three new questions in a conversational flow is a sprint; the same change in a multi-page HIPAA form is a quarter. The agility is itself a competitive advantage.

For regulatory context, the FDA maintains a public drug shortages list that drives the legal scope of compounding, and Hims & Hers' SEC filings detail the weight-loss segment.

How a $5B Telehealth Company Built Intake Without 'Forms'#

The Hims & Hers stack is custom-built by hundreds of engineers across a multi-year head start, treating intake as the core product rather than a wrapper around prescription. Most healthcare organizations cannot replicate that — but they can copy the four design principles:

1. Treat intake as the product. Most telehealth and clinic software treats intake as a tax patients endure to reach the "real" product. Hims & Hers treats intake as the point of brand contact — visual design, copy voice, tempo of questions, all of it. The clinical visit is almost a back-office step.

2. Branch on patient input, not on form logic. Traditional form builders branch on field values. Hims & Hers branches on patient intent and context — what they're trying to accomplish, what concerns they raised. That's a conversation, not a form.

3. One question per screen, on mobile. 70%+ of Hims & Hers' traffic is mobile. A 12-field form is unusable on a phone; a 12-question conversation feels effortless. Eye-tracking research from the Nielsen Norman Group has documented the single-question conversion lift for 15 years; Hims & Hers operationalized it at scale.

4. Reuse the conversation across the lifecycle. Refills, side-effect reporting, dose changes, primary-care add-ons all use the same conversational pattern — the same insight underlying the continuous discovery model for product teams, applied to a clinical relationship.

For healthcare orgs without a Hims-sized engineering budget, the news in 2026 is that you no longer need one. Conversational intake platforms — including Perspective AI's intelligent intake agent — deliver the same patient-side experience without the multi-year build. You write the clinical logic; the platform handles the chat UI, branching, secure capture, and handoff to your EHR or clinician inbox.

What Brick-and-Mortar Clinics and Health Systems Can Learn#

Hims & Hers is digital-native, async-first, and cash-pay — not most of healthcare. But several design choices port directly:

For multi-specialty clinics and primary care: move the pre-visit intake from clipboard or "patient portal" to a conversational SMS chat the day before the visit. Capture chief complaint, recent symptom changes, medication updates, and social-determinant context (transportation, housing, food security) that checkbox forms rarely catch. The clinician walks in already informed. The model is documented in the AI patient intake guide for healthcare practices.

For hospital systems: the highest-leverage deployment is ED and urgent-care intake, today the worst patient experience in healthcare. The Cleveland Clinic conversational intake program and the Mayo Clinic patient experience redesign both ship versions of this, and the One Medical / Amazon onboarding overhaul is a third reference architecture.

For specialty practices (derm, dental, behavioral health, PT): the Hims & Hers playbook is closest. Single-condition, single-flow, conversational intake that captures what the clinician needs and nothing extra — see the conversational AI medical intake guide.

For insurance plans deploying member-facing intake: adapt the same pattern for benefits, prior authorization, and care navigation. Examples include the Lemonade pet-insurance conversational onboarding case study and the Cover Genius embedded-insurance intake model.

Research published in JAMA Network Open and covered in Modern Healthcare has repeatedly documented that conversational pre-visit data capture improves chart accuracy and reduces clinician documentation time. The economic case is no longer aspirational.

Quick Comparison: Form-Based vs Conversational Patient Intake#

The numbers in this table are aggregated from public Hims & Hers disclosures, Perspective AI customer benchmarks, and intake-conversion data documented in the conversion gap between forms and conversations 4x analysis.

How Perspective AI Fits This Picture#

Perspective AI builds conversational intake and interview agents specifically for healthcare and other regulated industries that need form-replacement without a Hims-sized engineering team. The Perspective AI Concierge agent replaces patient intake forms with a conversational flow that branches on patient input, captures structured data, and hands off to your clinician inbox or EHR. The Perspective AI Interviewer runs longitudinal patient research — post-visit interviews, treatment-experience studies, condition-specific cohorts — at a depth that surveys can't reach.

If your team is rethinking intake for a telehealth product, a clinic group, or a payer-side member experience, the right place to start is Perspective AI's intelligent intake page and the intake template library, which includes pre-built starting points for patient intake, telehealth feedback, patient experience interviews, therapy intake, and several adjacent flows.

Frequently Asked Questions#

How does Hims & Hers handle HIPAA in its conversational intake?#

Hims & Hers operates as a HIPAA-covered entity, and its intake conversations run on infrastructure with BAA-backed encryption, access controls, and audit logging. The conversational format does not change HIPAA scope — it's protected health information from the first symptom entry. The lesson for other healthcare orgs is that conversational intake is not a regulatory exception; it must meet the same bar as a form, just with a better patient experience.

Is the Hims & Hers intake fully AI-driven or is there human review?#

It's a hybrid. The intake conversation is automated and runs against deterministic branching logic plus, in newer flows, AI-assisted interpretation of free-text fields. But every prescription is reviewed and signed by a licensed clinician before fulfillment. Hims & Hers has been explicit that the clinician is the prescribing decision-maker — the conversational intake is a structured input to that decision, not a replacement.

Why did Hims & Hers' GLP-1 line scale so fast?#

Three factors compounded. The conversational intake let the company onboard patients with high contraindication-screening accuracy without slowing conversion. Millions of existing customers could be cross-sold with a short intake addition rather than a fresh sign-up. And the company pivoted quickly to compounded semaglutide during the FDA shortage period, which required intake-flow changes most form-based competitors couldn't ship as fast. The intake architecture was the enabling layer.

Can a small clinic copy this approach without engineering resources?#

Yes, much more easily than in 2024. Conversational intake platforms — including Perspective AI's Concierge agent — let clinics build branching, mobile-friendly, HIPAA-aware intake without writing code. The clinic supplies the clinical logic; the platform handles the chat UI, secure data capture, and EHR or inbox handoff. The Hims & Hers experience was unreachable without a custom build two years ago; it's a one-week deployment today for most small and mid-sized practices.

What's the biggest mistake healthcare orgs make moving from forms to conversational intake?#

The biggest mistake is porting the form one-for-one into a chat UI — same questions, same order, same length, just with bubbles. The point of the conversation is to branch, to ask fewer questions when fewer are warranted and more when more are needed. A "chat-shaped form" gets the patient annoyance of a 40-field form with none of the conversion benefit. The redesign starts from the clinical decision tree, not the existing form.

Does conversational intake work for older patients?#

Yes, with design care. Older patients handle chat UIs well when the UI is well-designed: large buttons, short questions, no jargon, no required typing on the primary path, clear progress indicators. Primary-care groups serving Medicare populations have deployed conversational intake with completion rates equal to or higher than younger cohorts.

Conclusion#

Hims & Hers built a $5 billion telehealth business on a single design conviction: ai patient intake healthcare workflows belong in conversations, not forms. The intake is not a feature of the product — it is the product. That conviction is why a DTC men's-health brand scaled into weight loss, mental health, primary care, and dermatology without rebuilding its funnel each time, and why it captured ~$1.2 billion in GLP-1 run-rate in 18 months while form-based competitors are still iterating on field order.

The good news for everyone else — telehealth startups, multi-specialty clinics, hospital systems, payers, specialty practices — is that you no longer need Hims-scale engineering to ship the Hims-scale experience. The remaining work is clinical: deciding what questions matter, how the conversation should branch, and how the structured output reaches a clinician.

If you're rethinking patient intake for 2026, start a Perspective AI research project or see the Concierge intake agent. The form era of healthcare intake is closing — and Hims & Hers already proved the conversational era works.